{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:04:40Z","timestamp":1781175880907,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>RA patients are often prescribed glucocorticoids, although it is known that their long-term use increases the risk of osteoporosis and fractures. The association between glucocorticoid use and RA-associated cervical spine deformity is yet to be determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Duration and dose of glucocorticoid use were evaluated in patients with new onset RA (BeSt Trial). Missing values on the exposure were imputed using the last observation carried forward. Lateral X-rays at 5- and 10-year follow-ups were assessed for atlantoaxial subluxation (AAS) and subaxial subluxation (SAS). To estimate the association between glucocorticoids and cervical spine deformity, multiple logistic regression models adjusted for age, gender, baseline Disease Activity Score (DAS), ACPA positivity, and RF positivity were used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs). Mediation analysis was performed to evaluate whether such potential association was mediated via mean DAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Cervical deformity (AAS and\/or SAS\u2009&gt;\u20092\u00a0mm) was observed in 108 (40%) out of 272 patients. For a 1-year increase in total duration of glucocorticoid use, the adjusted OR for RA-associated cervical spine deformity was 1.19 (95% CI, 1.03\u20131.38; <jats:italic>p<\/jats:italic>\u2009=\u20090.02), and for an increase of 1\u00a0g of glucocorticoid in total cumulative dose, the OR was 1.06 (95% CI, 1.01\u20131.12; <jats:italic>p<\/jats:italic>\u2009=\u20090.02). Mediation analysis could not reveal an influence of mean DAS on these associations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There was evidence of a direct association between long-term use of glucocorticoids in newly diagnosed RA patients and RA-associated cervical spine deformity after 10\u00a0years. Other effective therapies to suppress disease activity may be preferred over glucocorticoids.\n<jats:table-wrap>\n                <jats:table>\n                  <jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\">\n                        <jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>For a 1-year increase in total duration of prednisone use in RA patients, the adjusted OR for RA-associated cervical spine deformity was 1.17 (95% CI, 1.01\u20131.36; p\u2009=\u20090.04).<\/jats:italic>\u2022 <jats:italic>For an increase in total cumulative dose of 1 g of prednisone in RA patients, the adjusted OR for RA-associated cervical spine deformity was 1.06 (95% CI, 1.00\u20131.11; p\u2009=\u20090.04).<\/jats:italic>\u2022 <jats:italic>The use of glucocorticoids in RA patients was associated with an increased odds of RA-associated cervical spine deformity after 10 years, which may suggest that other effective therapies to suppress disease activity should be preferred over glucocorticoids.<\/jats:italic>\n                      <\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody>\n                <\/jats:table>\n              <\/jats:table-wrap>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10067-025-07408-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T21:16:16Z","timestamp":1743887776000},"page":"1919-1926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-4729","authenticated-orcid":false,"given":"Anna B.","family":"Lebouille-Veldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W. J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Mekary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L. A.","family":"Vleggeert-Lankamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"13","key":"7408_CR1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"issue":"1","key":"7408_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 american college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1\u201326. https:\/\/doi.org\/10.1002\/art.39480","journal-title":"Arthritis Rheumatol"},{"key":"7408_CR3","doi-asserted-by":"publisher","unstructured":"van der Goes MC, Jacobs JW, Bijlsma JW (2014) The value of glucocorticoid co-therapy in different rheumatic diseases\u2013positive and adverse effects. Arthritis Res Ther 16(Suppl 2).\u00a0https:\/\/doi.org\/10.1186\/ar4686. (S2)","DOI":"10.1186\/ar4686"},{"issue":"1","key":"7408_CR4","doi-asserted-by":"publisher","first-page":"CD006356","DOI":"10.1002\/14651858.CD006356","volume":"2007","author":"JR Kirwan","year":"2007","unstructured":"Kirwan JR, Bijlsma JW, Boers M, Shea BJ (2007) Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007(1):CD006356. https:\/\/doi.org\/10.1002\/14651858.CD006356","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"7408_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/annrheumdis-2021-221957","volume":"81","author":"M Boers","year":"2022","unstructured":"Boers M, Hartman L, Opris-Belinski D et al (2022) Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Ann Rheum Dis 81(7):925\u2013936. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221957","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7408_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.38210","volume":"66","author":"I del Rincon","year":"2014","unstructured":"del Rincon I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66(2):264\u2013272. https:\/\/doi.org\/10.1002\/art.38210","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 2","key":"7408_CR7","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/rheumatology\/kew344","volume":"55","author":"JWJ Bijlsma","year":"2016","unstructured":"Bijlsma JWJ, Buttgereit F (2016) Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies. Rheumatology (Oxford) 55(suppl 2):ii3\u2013ii5. https:\/\/doi.org\/10.1093\/rheumatology\/kew344","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"7408_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J et al (2006) Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55(3):420\u2013426. https:\/\/doi.org\/10.1002\/art.21984","journal-title":"Arthritis Rheum"},{"issue":"7","key":"7408_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68(7):1119\u20131124. https:\/\/doi.org\/10.1136\/ard.2008.092163","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7408_CR10","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/rheumatology\/kead088","volume":"62","author":"A Palmowski","year":"2023","unstructured":"Palmowski A, Nielsen SM, Boyadzhieva Z et al (2023) Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 62(8):2652\u20132660. https:\/\/doi.org\/10.1093\/rheumatology\/kead088","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"7408_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/annrheumdis-2022-222339","volume":"81","author":"E Wiebe","year":"2022","unstructured":"Wiebe E, Huscher D, Schaumburg D et al (2022) Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis 81(9):1313\u20131322. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222339","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7408_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/ard-2022-223358","volume":"82","author":"SA Bergstra","year":"2023","unstructured":"Bergstra SA, Sepriano A, Kerschbaumer A et al (2023) Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 82(1):81\u201394. https:\/\/doi.org\/10.1136\/ard-2022-223358","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7408_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 73(7):924\u2013939. https:\/\/doi.org\/10.1002\/acr.24596","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"7408_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/ard.2003.020230","volume":"64","author":"MJ Kauppi","year":"2005","unstructured":"Kauppi MJ, Barcelos A, da Silva JA (2005) Cervical complications of rheumatoid arthritis. Ann Rheum Dis 64(3):355\u2013358. https:\/\/doi.org\/10.1136\/ard.2003.020230","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7408_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/1756-185X.13096","volume":"20","author":"S Zhu","year":"2017","unstructured":"Zhu S, Xu W, Luo Y, Zhao Y, Liu Y (2017) Cervical spine involvement risk factors in rheumatoid arthritis: a meta-analysis. Int J Rheum Dis 20(5):541\u2013549. https:\/\/doi.org\/10.1111\/1756-185X.13096","journal-title":"Int J Rheum Dis"},{"key":"7408_CR16","doi-asserted-by":"publisher","first-page":"9403883","DOI":"10.1155\/2022\/9403883","volume":"2022","author":"AB Veldman","year":"2022","unstructured":"Veldman AB, Allaart CF, Vleggeert-Lankamp CLA (2022) The influence of reducing disease activity score on cervical spine deformity in rheumatoid arthritis: a systematic review. Biomed Res Int 2022:9403883. https:\/\/doi.org\/10.1155\/2022\/9403883","journal-title":"Biomed Res Int"},{"key":"7408_CR17","doi-asserted-by":"publisher","unstructured":"Lebouille-Veldman AB, Spenkelink D, Allaart CF, Vleggeert-Lankamp CLA (2023) The association between disease activity score and rheumatoid arthritis-associated cervical deformity: radiological evaluation of the BeSt trial. J Neurosurg Spine 1\u20138. https:\/\/doi.org\/10.3171\/2022.12.SPINE221057","DOI":"10.3171\/2022.12.SPINE221057"},{"key":"7408_CR18","doi-asserted-by":"publisher","unstructured":"Lebouille-Veldman AB, Allaart CF, Vleggeert-Lankamp CLA (2025) Cervical spine deformity and flares in disease activity in rheumatoid arthritis. Brain and Spine 5:104235. https:\/\/doi.org\/10.1016\/j.bas.2025.104235","DOI":"10.1016\/j.bas.2025.104235"},{"issue":"8","key":"7408_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7326\/m15-0919","volume":"164","author":"IM Markusse","year":"2016","unstructured":"Markusse IM, Akdemir G, Dirven L et al (2016) Long-term outcomes of patients with recent-onset rheumatoid arthritis after 10 years of tight controlled treatment: a randomized trial. Ann Intern Med 164(8):523\u2013531. https:\/\/doi.org\/10.7326\/m15-0919","journal-title":"Ann Intern Med"},{"issue":"7","key":"7408_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5435\/00124635-200511000-00006","volume":"13","author":"DH Kim","year":"2005","unstructured":"Kim DH, Hilibrand AS (2005) Rheumatoid arthritis in the cervical spine. J Am Acad Orthop Surg 13(7):463\u2013474. https:\/\/doi.org\/10.5435\/00124635-200511000-00006","journal-title":"J Am Acad Orthop Surg"},{"key":"7408_CR21","unstructured":"MDCalc. https:\/\/www.mdcalc.com\/calc\/2040\/steroid-conversion-calculator#why-use. Accessed 24 July 2024"},{"key":"7408_CR22","unstructured":"IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp"},{"key":"7408_CR23","unstructured":"Inc. TM. MATLAB version 2019b. The MathWorks Inc. https:\/\/www.mathworks.com . Accessed 24 July 2024"},{"issue":"8","key":"7408_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/BRS.0000000000001853","volume":"42","author":"Y Terashima","year":"2017","unstructured":"Terashima Y, Yurube T, Hirata H, Sugiyama D, Sumi M, Hyogo Organization of Spinal D (2017) Predictive risk factors of cervical spine instabilities in rheumatoid arthritis: a prospective multicenter over 10-year cohort study. Spine (Phila Pa 1976) 42(8):556\u2013564. https:\/\/doi.org\/10.1097\/BRS.0000000000001853","journal-title":"Spine (Phila Pa 1976)"},{"issue":"10","key":"7408_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00296-010-1437-y","volume":"31","author":"JK Ahn","year":"2011","unstructured":"Ahn JK, Hwang JW, Oh JM et al (2011) Risk factors for development and progression of atlantoaxial subluxation in Korean patients with rheumatoid arthritis. Rheumatol Int 31(10):1363\u20131368. https:\/\/doi.org\/10.1007\/s00296-010-1437-y","journal-title":"Rheumatol Int"},{"issue":"1","key":"7408_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10067-003-0782-6","volume":"23","author":"P Pisitkun","year":"2004","unstructured":"Pisitkun P, Pattarowas C, Siriwongpairat P, Totemchokchyakarn K, Nantiruj K, Janwityanujit S (2004) Reappraisal of cervical spine subluxation in Thai patients with rheumatoid arthritis. Clin Rheumatol 23(1):14\u201318. https:\/\/doi.org\/10.1007\/s10067-003-0782-6","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07408-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:13:00Z","timestamp":1747210380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07408-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7408"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07408-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}